Theravance Company Profile

00:06 EDT 20th June 2018 | BioPortfolio

Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. Theravance is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. Theravance's key programmes include: RELVAR™ ELLIPTA™ or BREO™ ELLIPTA™ (FF/VI), ANORO™ ELLIPTA™ (UMEC/VI) and MABA (Bifunctional Muscarinic Antagonist-Beta2 Agonist), each partnered with GlaxoSmithKline plc, and its oral Peripheral Mu Opioid Receptor Antagonist program. By leveraging its proprietary insight of multivalency to drug discovery, Theravance is pursuing a best-in-class strategy designed to discover superior medicines in areas of significant unmet medical need. 


901 Gateway Blvd.
South San Francisco
United States of America


Phone: 650-808-6000

News Articles [42 Associated News Articles listed on BioPortfolio]

J&J Gambles $1B on Theravance and Its GI Pipeline

J&J inked a global collaboration deal with Theravance Biopharma to develop a drug for IBD.

Theravance set to earn up to $1 billion from TD-1473 deal

Ireland-incorporated Theravance Biopharma saw its shares rocket more than 16% to $28.38 in morning trading…

Theravance's NDA for COPD therapy accepted for FDA review

Theravance Biopharma's new-drug application for revefenacin, or TD-4208, as a once-daily treatment for patients with chronic  -More- 

Theravance Snares $100M From Janssen in Stomach Drug Deal

Theravance Biopharma is teaming up with Janssen Biotech to develop a group of drugs for intestinal diseases such as ulcerative colitis and Crohn’s. Dublin, Ireland based-Theravance Biopharma (NASDAQ...

Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease

DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Jan. 29, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ, TASE: MYL) ("Mylan") today an...

FDA Accepts Theravance and Mylan’s NDA for Revefenacin for the Treatment of Adults with COPD

DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Jan. 29, 2018 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma”) and Mylan N.V. (NASDAQ, TA...

Janssen signs inflammatory intestinal disease deal with Theravance

The Janssen Biotech unit of Johnson & Johnson will co-develop and market Theravance Biopharma's pan-Janus kinase inhibitor TD -More- 

Theravance Biopharma And Mylan Announce FDA Acceptance Of NDA For Revefenacin

CANONSBURG (dpa-AFX) - Theravance Biopharma Inc. (TBPH) and Mylan N.V. (MYL) said that the U.S. Food and Drug Administration or FDA has accepted for review the companies' recently submitted New Dr...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]


Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. Theravance is focused on the discove...

Innoviva, Inc.

Innoviva is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and finan...

More Information about "Theravance" on BioPortfolio

We have published hundreds of Theravance news stories on BioPortfolio along with dozens of Theravance Clinical Trials and PubMed Articles about Theravance for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Theravance Companies in our database. You can also find out about relevant Theravance Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Corporate Database Quicklinks

Searches Linking to this Company Record